Clinical trial · Observational
Chemotherapy Monitoring With Breast Computed Tomography (CT)
Breast Cancer Chemotherapy Monitoring With Dedicated Breast Computed Tomography
NCT00808041CI-TRIAL-00018639completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to determine if dedicated breast computed tomography can be used successfully to monitor tumor response in breast cancer patients undergoing neoadjuvant chemotherapy.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Dedicated breast computed tomography imaging | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Treatment
- description
- Breast cancer patients undergoing hormonal therapy before surgery.
- interventionNames
- Device: Dedicated breast computed tomography imaging
Primary outcomes (1)
- measure
- Tumor response
- timeFrame
- Mid-treatment and post-treatment completion
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
3.1 Eligibility Criteria * All subjects will be women at least 18 years of age that will undergo standard or research pre-operative hormonal therapy for breast cancer before lumpectomy or mastectomy. * Women who have undergone pre treatment breast MR imaging to verify that no additional findings are present. 3.2 Ineligibility Criteria * Subject does not meet any of the inclusion criteria * Women with suspected or confirmed pregnancy * Women who have had bilateral mastectomy * Women who are unable to remain in a prone position on the BCT system for the required amount of time * Women who cannot give informed consent * Women with metastasis * Male subjects * Women with implants * Women with breast augmentation, except for unilateral augmentation done for prior mastectomy * Women who are allergic to iodine * Women with physical limitations such as, but not limited to: frozen shoulder, recent heart surgery, pace maker, neck problems or any other condition that would prohibit them from lying face down * Women who have had problems or reactions to contrast, such as nausea/vomiting, itching, hives, B/P changes, respirator distress, cardiac arrest. * Women with history of Diabetes, kidney disease, kidney surgery, dialysis, heart disease-such as Congestive Heart Failure, Multiple Myeloma, Sickle Cell Anemia, Lupus, Rheumatoid Arthritis or other Autoimmune disease, recent surgery, chemotherapy, dehydration, high use of NSAIDs such as Ibuprofen
References
Publications (0)
Data not yet available
No reference posted for this study.